Showing 41 - 50 of 309
Green light for local favipiravir production
Phusadee Arunmas, Published on 05/05/2021
» The Department of Intellectual Property has rejected the developer of the drug favipiravir's latest patent application, paving the way for local production of the antiviral medication now widely used to treat Covid-19 patients.
AI 'is no more of an inventor than your cat'
Business, Upmanyu Trivedi, Published on 04/03/2023
» If an artificial intelligence (AI) machine can be named as an inventor for a patent, pet cats could be next, lawyers said at the United Kingdom's top court, arguing only humans can be inventors in law.
Depa vows to help local companies register patents
Business, Komsan Tortermvasana, Published on 19/05/2021
» The Digital Economy Promotion Agency (Depa) is gearing up to support local firms seeking to register patents for digital work through its intellectual property (IP) voucher programme in a bid to promote the digital economy and the country's IP index.
US judge recommends partial ban on iPhone imports to US
AFP, Published on 27/03/2019
» SAN FRANCISCO: A US trade judge ruled Tuesday that Apple had violated a Qualcomm chipmaker patent and said she would recommend banning imports of some iPhones.
S44 'not fit' for cannabis regulation
News, Apinya Wipatayotin, Published on 28/11/2018
» FTA Watch, a non-governmental body monitoring free trade agreements, has expressed its disapproval of the regime's plan to invoke Section 44 to deal with contentious issues surrounding requests to patent marijuana extracts.
Pot patents stretching the envelope
News, Phusadee Arunmas, Published on 16/11/2018
» A Commerce Ministry-appointed panel has been given one week to finish examining controversial applications for marijuana extract patents as opponents plan a huge rally against decriminalising the drug for certain usages.
Weed on road to legalisation
News, Aekarach Sattaburuth, Published on 26/12/2018
» A bill to legalise the strictly controlled production, import and use of marijuana and kratom for medical and research purposes was passed yesterday, amid concerns that patents on marijuana extracts will be secured mainly by large, foreign pharmaceutical companies.
CPTPP could lead to 'soaring' health costs
News, Post Reporters, Published on 18/07/2020
» The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) will cost Thailand considerably more in medicines and make the country further reliant on imported drugs while leaving state-owned drugmakers in a difficult position, according to a study by Chulalongkorn University.
Improved IP rights crucial to progress
Business, Published on 10/10/2019
» Thailand is among the Asean countries that must raise their intellectual property rights (IPR) frameworks and enforcement mechanisms in line with global standards in order to join the ranks of high-income countries, new research by the Geneva Network shows.
Biothai wades into patents row
News, Post Reporters, Published on 19/11/2018
» An advocacy group is calling on the Department of Intellectual Property to better regulate the patenting of cannabis extracts in traditional Thai medicines.